Azithromycin modulates neutrophil function and circulating inflammatory mediators in healthy human subjects

Abe, 2000, Interleukin-8 gene repression by clarithromycin is mediated by the activator protein-1 binding site in human bronchial epithelial cells, Am. J. Respir. Cell Mol. Biol., 22, 51, 10.1165/ajrcmb.22.1.3400 Agen, 1993, Macrolide antibiotics as anti-inflammatory agents: roxithromycin in an unexpected role, Agents Actions, 38, 85, 10.1007/BF02027218 Akgul, 2001, Molecular control of neutrophil apoptosis, FEBS Lett., 487, 318, 10.1016/S0014-5793(00)02324-3 Amsden, 2001, Serum and WBC pharmacokinetics of 1500 mg of azithromycin when given either as a single dose or over a 3 day period in healthy volunteers, J. Antimicrob. Chemother., 47, 61, 10.1093/jac/47.1.61 Amsden, 1999, Pharmacokinetics in serum and leukocyte exposures of oral azithromycin, 1500 milligrams, given over a 3- or 5-day period in healthy subjects, Antimicrob. Agents Chemother., 43, 163, 10.1128/AAC.43.1.163 Anderson, 1989, Erythromycin and roxithromycin potentiate human neutrophil locomotion in vitro by inhibition of leukoattractant-derived superoxide generation and auto-oxidation, J. Infect. Dis., 159, 966, 10.1093/infdis/159.5.966 Anisowicz, 1987, Constitutive overexpression of a growth-regulated gene in transformed Chinese hamster and human cells, Proc. Natl. Acad. Sci. U. S. A., 84, 7188, 10.1073/pnas.84.20.7188 Aoshiba, 1995, Erythromycin shortens neutrophil survival by accelerating apoptosis, Antimicrob. Agents Chemother., 39, 872, 10.1128/AAC.39.4.872 Baker, 1990, Microtiter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples, Anal. Biochem., 190, 360, 10.1016/0003-2697(90)90208-Q Barnes, 1997, Nuclear factor-κB—a pivotal transcription factor in chronic inflammatory diseases, New Engl. J. Med., 336, 1066, 10.1056/NEJM199704103361506 Bonnet, 1992, In vitro and in vivo intraleukocytic accumulation of azithromycin (CP-62,993) and its influence on ex vivo leukocyte chemiluminescence, Antimicrob. Agents Chemother., 36, 1302, 10.1128/AAC.36.6.1302 Borregaard, 1994, Changes in subcellular localization and surface expression on selectin, alkaline phospatase, and Mac-1 in human neutrophil during stimulation with inflammatory mediators, J. Leukoc. Biol., 56, 80, 10.1002/jlb.56.1.80 Brown, 1991, Comparison of the response of bovine and human neutrophils to various stimuli, Vet. Immunol. Immunopathol., 28, 201, 10.1016/0165-2427(91)90115-S Calver, 1993, Nitric oxide and cardiovascular control, Exp. Physiol., 78, 303, 10.1113/expphysiol.1993.sp003687 Cassatella, 1999, Neutrophil-derived proteins: selling cytokines by the pound, Adv. Immunol., 73, 369, 10.1016/S0065-2776(08)60791-9 Chin, 2000, Tilmicosin induces apoptosis in bovine peripheral neutrophils in the presence or in absence of Pasteurella hemolytica and promotes neutrophil phagocytosis by macrophages, Antimicrob. Agents Chemother., 44, 2465, 10.1128/AAC.44.9.2465-2470.2000 Ching, 1995, The effect of histamine on the oxidative burst of HL-60 cells before and after exposure to reactive oxygen species, Inflamm. Res., 44, 99, 10.1007/BF01782018 Cohen, 1978, Superoxide generation by digitonin-stimulated guinea pig granulocytes. A basis for a continuous assay for monitoring superoxide production and for the study of the generating system, J. Clin. Invest., 61, 1081, 10.1172/JCI109007 Čulić, 2001, Anti-inflammatory effects of macrolide antibiotics, Eur. J. Pharmacol., 429, 209, 10.1016/S0014-2999(01)01321-8 Čulić, 2002, Azithromycin and resting host defence mechanisms in healthy human subjects, 141 Culling, 1985, 305 Desaki, 2000, Erythromycin suppresses nuclear factor-kappa B and activator protein-1 activation in human bronchial epithelial cells, Biochem. Biophys. Res. Commun., 267, 124, 10.1006/bbrc.1999.1917 Dumont, 2000, FK506, An immunosuppressant targeting calcineurin function, Curr. Med. Chem., 7, 731, 10.2174/0929867003374723 English, 1974, Single-step separation of red blood cells, granulocytes and mononuclear leukocytes on discontinuous density gradients of Ficoll-Hypaque, J. Immunol. Methods, 5, 249, 10.1016/0022-1759(74)90109-4 Eyer, 1986, Evaluation of the micromethod for determination of glutathione using enzymatic cycling and Ellman's reagent, Anal. Biochem., 153, 57, 10.1016/0003-2697(86)90061-8 Fernandez-Segura, 1995, Dynamic reorganization of the alkaline phosphate-containing compartment during chemotactic peptide stimulation of human neutrophils imaged by backscattered electrons, Histochem. Cell Biol., 104, 175, 10.1007/BF01451577 Foulds, 1990, The pharmacokinetics of azithromycin in human serum and tissues, J. Antimicrob. Chemother., 25, 73, 10.1093/jac/25.suppl_A.73 Fujita, 1983, Color reaction between pyrogallol red/molibdenum (VI) complex and protein, Bunseki Kagaku, 32, 379, 10.2116/bunsekikagaku.32.12_E379 Gaston, 1994, The biology of nitrogen oxides in the airways, Am. J. Respir. Crit. Care Med., 149, 538, 10.1164/ajrccm.149.2.7508323 Glaser, 1973, Beta-glucuronidase deficiency mucopolysaccharidosis: methods for enzyme diagnosis, J. Lab. Clin. Med., 82, 969 Glojnarić, 2000, Automatic determination of superoxide dismutase, glutathione peroxidase and β2-microglobulin in human neutrophils, Biochem. Med., 10, 69 Granger, 1996, Nitric oxide as antiinflammatory agent, Methods Enzymol., 269, 434, 10.1016/S0076-6879(96)69044-2 Green, 1982, Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids, Anal. Biochem., 126, 131, 10.1016/0003-2697(82)90118-X Greiling, 1989, 1048 Griffith, 1980, Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine, Anal. Biochem., 106, 207, 10.1016/0003-2697(80)90139-6 Huntley, 1985, Histochemical demonstration of chymotrypsin like serine esterase in mucosal mast cells in four species including man, J. Clin. Pathol., 38, 375, 10.1136/jcp.38.4.375 Ianaro, 2000, Anti-inflammatory activity of macrolide antibiotics, J. Pharmacol. Exp. Ther., 292, 156 Kettritz, 1998, Interleukin-8 delays spontaneous and tumor necrosis facto-alpha-mediated apoptosis of human neutrophils, Kidney Int., 53, 84, 10.1046/j.1523-1755.1998.00741.x Khair, 1995, Effects of erythromycin on Haemophilus influenzae endotoxin-induced release of IL-6, IL-8 and sICAM-1 by cultured human bronchial epithelial cells, Eur. Respir. J., 8, 1451, 10.1183/09031936.95.08091451 Khan, 1999, Effects of clarithromycin and azithromycin on production of cytokines by human monocytes, Int. J. Antimicrob. Agents, 11, 121, 10.1016/S0924-8579(98)00091-0 Koch, 2000, Apoptosis, oxidative metabolism and interleukin-8 production on human neutrophils exposed to azithromycin: effects of Streptococcus pneumoniae, J. Antimicrob. Chemother., 46, 19, 10.1093/jac/46.1.19 Kurdowska, 2001, The effect of azithromycin and clarithromycin on ex vivo interleukin-8 (IL-8) release from whole blood and IL-8 production by human alveolar macrophages, J. Antimicrob. Chemother., 47, 867, 10.1093/jac/47.6.867 Labro, 2000, Interference of antibacterial agents with phagocyte functions: immunomodulation or “immuno-fairy tales”?, Clin. Microbiol. Rev., 13, 615, 10.1128/CMR.13.4.615-650.2000 Liang, 1990, Signal transduction in N-formyl-methionyl-leucyl-phenylalanine and concanavalin a stimulated human neutrophils: superoxide production without a rise in intracellular free calcium, J. Cell Physiol., 145, 295, 10.1002/jcp.1041450214 Lin, 2000, Erythromycin inhibits beta2-integrins (CD11b/CD18) expression, interleukin-8 release and intracellular oxidative metabolism in neutrophils, Respir. Med., 94, 654, 10.1053/rmed.1999.0781 Matsuoka, 1996, Inhibitory effect of clarithromycin on constimulatory molecule expression and cytokine production by synovial fibroblast-like cells, Clin. Exp. Immunol., 104, 501, 10.1046/j.1365-2249.1996.46752.x Mazzei, 1993, Chemistry and mode of action of macrolides, J. Antimicrob. Chemother., 31, 1, 10.1093/jac/31.suppl_C.1 McKenzie, 1996, 615 Moncada, 1991, Nitric oxide: physiology, pathophysiology, and pharmacology, Pharmacol. Rev., 43, 109 Morikawa, 1996, Modulatory effects of antibiotics on cytokine production by human monocytes in vitro, Antimicrob. Agents Chemother., 40, 1366, 10.1128/AAC.40.6.1366 Moshage, 1995, Nitrite and nitrate determinations in plasma: a critical evaluation, Clin. Chem., 41/6, 892, 10.1093/clinchem/41.6.892 Munić, 2001, Macrolide uptake and release by HL-60 cells and human polymorphonuclear neutrophils (PMN), Period. Biol., 103, 96 Nelson, 1977, Leukocytes studies, 155 Novak Mirčetić, 2001, Influence of azithromycin on human neutrophil degranulation, Clin. Chem. Lab. Med., 39, S397 O'Brien, 1970, Tay-Sachs disease. Detection of heterozygotes and homozygotes by serum hexosaminidase assay, New Engl. J. Med., 283, 15, 10.1056/NEJM197007022830104 Olsen, 1996, Intrapulmonary pharmacokinetics of azithromycin in healthy volunteers given five oral doses, Antimicrob. Agents Chemother., 40, 2582, 10.1128/AAC.40.11.2582 Paglia, 1967, Studies on quantitative and qualitative characterization of erythrocyte gluthathione peroxidase, J. Lab. Clin. Med., 70, 158 Parnham, 1987, Changes in glutathione peroxidase activities and the oxidative burst of leucocytes during inflammation in the mouse and rat, Free Radic. Res. Commun., 4, 183, 10.3109/10715768709088103 Robinson, 1983, Determination of ideal body weight for drug dosage calculations, Am. J. Hosp. Pharm., 40, 1016 Sala, 2001, Neutrophils, endothelial cells, and cysteinyl leukotrienes: a new approach to neutrophil-dependent inflammation?, Biochem. Biophys. Res. Commun., 283, 1003, 10.1006/bbrc.2001.4865 Shoji, 1998, Erythromycin treatment in diffuse panbronchiolitis, Curr. Opin. Pulm. Med., 4, 116, 10.1097/00063198-199803000-00010 Squier, 1995, Apoptosis in leukocytes, J. Leukoc. Biol., 57, 2, 10.1002/jlb.57.1.2 Takeshita, 1989, Immunological and anti-inflammatory effects of clarithromycin: inhibition of interleukin 1 production of murine peritoneal macrophages, Drugs Exp. Clin. Res., 15, 527 Tietze, 1969, Enzymatic method for quantitative determination of nanogram amounts of total and oxidised glutathione: applications to mammalian blood and other tissues, Anal. Biochem., 27, 502, 10.1016/0003-2697(69)90064-5 Viedma Contreras, 1999, Leucocyte activation markers in clinical practice, Clin. Chem. Lab. Med., 37, 607, 10.1515/CCLM.1999.096 Wang, 1997, Evidence for the involvement of protein kinase C inhibition by norathyriol in the reduction of phorbol ester-induced neutrophil superoxide anion generation and aggregation, Eur. J. Pharmacol., 336, 81, 10.1016/S0014-2999(97)01214-4 Watanabe, 1986, Urinary protein as measured with pyrogallol red-molybdate complex manually and in Hitachi 726 automated analyser, Clin. Chem., 32, 1551, 10.1093/clinchem/32.8.1551 Wenisch, 1996, Effect of a single oral dose of azithromycin, clarithromycin, and roxithromycin on polymorphonuclear leukocyte function assessed ex vivo by flow cytometry, Antimicrob. Agents Chemother., 40, 2039, 10.1128/AAC.40.9.2039 Williams, 1993, Comparison of macrolide antibiotics, J. Antimicrob. Chemother., 31, 11, 10.1093/jac/31.suppl_C.11 Wyllie, 1980, Cell death: the significance of apoptosis, Int. Rev. Cyt., 68, 251, 10.1016/S0074-7696(08)62312-8 Xu, 1996, Effects of macrolide antibiotics on macrophage functions, Microbiol. Immunol., 40, 473, 10.1111/j.1348-0421.1996.tb01097.x Yam, 1971, Cytochemical identification of monocytes and granulocytes, Am. J. Clin. Pathol., 55, 283, 10.1093/ajcp/55.3.283 Zuckerman, 2000, The newer macrolides: azithromycin and clarithromycin, Infect. Dis. Clin. North Am., 14, 449, 10.1016/S0891-5520(05)70257-9